Scalable interrogation : Eliciting human pheromone responses to deception in a security interview setting

Individuals trying to conceal knowledge from interrogators are likely to experience raised levels of stress that can manifest itself across biological, physiological, psychological and behavioural factors, providing an opportunity for detection. Using established research paradigms an innovative scalable interrogation was designed in which participants were given a ‘token’ that represented information they had to conceal from interviewers. A control group did not receive a token and therefore did not have to deceive the investigators. The aim of this investigation was to examine differences between deceivers and truth-tellers across the four factors by collecting data for cortisol levels, sweat samples, heart-rate, respiration, skin temperature, subjective stress ratings and video and audio recordings. The results provided an integrated understanding of responses to interrogation by those actively concealing information and those acting innocently. Of particular importance, the results also suggest, for the first time in an interrogation setting, that stressed individuals may secrete a volatile steroid based marker that could be used for stand-off detection. The findings are discussed in relation to developing a scalable interrogation protocol for future research in this area

The optimal negligence standard in health care under supply-side cost sharing

Medical malpractice, Negligence rule, Court errors, Defensive medicine, I11, K13,

Genetic Variants Identified in a European Genome-Wide Association Study That Were Found to Predict Incident Coronary Heart Disease in the Atherosclerosis Risk in Communities Study

In 2007, the Wellcome Trust Case Control Consortium (WTCCC) performed a genome-wide association study in 2,000 British coronary heart disease (CHD) cases and 3,000 controls after genotyping 469,557 single nucleotide polymorphisms (SNPs). Seven variants associated with CHD were initially identified, and 5 SNPs were later found in replication studies. In the current study, the authors aimed to determine whether the 12 SNPs reported by the WTCCC predicted incident CHD through 2004 in a biracial, prospective cohort study (Atherosclerosis Risk in Communities) comprising 15,792 persons aged 45–64 years who had been selected by probability sampling from 4 different US communities in 1987–1989. Cox proportional hazards models with adjustment for age and gender were used to estimate CHD hazard rate ratios (HRRs) over a 17-year period (1,362 cases in whites and 397 cases in African Americans) under an additive genetic model. The results showed that 3 SNPs in whites (rs599839, rs1333049, and rs501120; HRRs were 1.10 (P = 0.044), 1.14 (P < 0.001), and 1.14 (P = 0.030), respectively) and 1 SNP in African Americans (rs7250581; HRR = 1.60, P = 0.05) were significantly associated with incident CHD. This study demonstrates that genetic variants revealed in a case-control genome-wide association study enriched for early disease onset may play a role in the genetic etiology of CHD in the general population